Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Net Loans Change in Receivables Change in Receivables Change in Taxes Change in Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other financing activities Other financing activities Preferred Shares Issued Preferred Shares Repurchased Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Fortress Biotech (FBIO) Cash from Investing Activities (2016 - 2025)

Fortress Biotech has reported Cash from Investing Activities over the past 13 years, most recently at $2.9 million for Q3 2025.

Quarterly results put Cash from Investing Activities at $2.9 million for Q3 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $10.1 million (up 167.47% YoY), and the annual figure for FY2025 was $10.1 million, up 167.47%.
Cash from Investing Activities for Q3 2025 was $2.9 million at Fortress Biotech, down from $6.1 million in the prior quarter.
Over the last five years, Cash from Investing Activities for FBIO hit a ceiling of $53.4 million in Q4 2021 and a floor of -$21.3 million in Q1 2022.
Median Cash from Investing Activities over the past 5 years was -$424500.0 (2021), compared with a mean of $662750.0.
Biggest five-year swings in Cash from Investing Activities: soared 3504.79% in 2021 and later tumbled 23709.52% in 2024.
Fortress Biotech's Cash from Investing Activities stood at $53.4 million in 2021, then plummeted by 100.73% to -$391000.0 in 2022, then surged by 83.89% to -$63000.0 in 2023, then tumbled by 23709.52% to -$15.0 million in 2024, then soared by 119.13% to $2.9 million in 2025.
The last three reported values for Cash from Investing Activities were $2.9 million (Q3 2025), $6.1 million (Q2 2025), and $1.2 million (Q1 2025) per Business Quant data.